Most cited papers from German Liver Foundation

German Liver Foundation

What are the most cited papers from German Liver Foundation?

The most cited paper from German Liver Foundation is "Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study" (Katja Deterding et al., 2016), with 131 citations. Next come "The surgical approach for locking plate osteosynthesis of displaced proximal humeral fractures influences the functional outcome" (131) and "Survival trends and predictors of mortality in severe pelvic trauma: Estimates from the German Pelvic Trauma Registry Initiative" (125).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 61 papers. Every paper with more than 9 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Ledipasvir plus sofosbuvir fixed-dose combination for 6 weeks in patients with acute hepatitis C virus genotype 1 monoinfection (HepNet Acute HCV IV): an open-label, single-arm, phase 2 study Katja Deterding et al. · The Lancet Infectious Diseases	28 Oct 2016	131
2	The surgical approach for locking plate osteosynthesis of displaced proximal humeral fractures influences the functional outcome Pierre Hepp, Jan Theopold, Christine Voigt et al. · Journal of Shoulder and Elbow Surgery	4 Dec 2007	131
3	Survival trends and predictors of mortality in severe pelvic trauma: Estimates from the German Pelvic Trauma Registry Initiative Tim Pohlemann, Dirk Stengel, Georgios Tosounidis et al. · Injury	25 Apr 2011	125
4	Appropriate referral and selection of patients with chronic pain for spinal cord stimulation: European consensus recommendations and e‐health tool Simon Thomson, Frank J.P.M. Huygen, Simon J. Prangnell et al. · European Journal of Pain Open access	18 Mar 2020	100
5	Direct‐acting antiviral treatment of chronic HCV‐infected patients on opioid substitution therapy: Still a concern in clinical practice? Stefan Christensen, Peter Buggisch, Stefan Mauss et al. · Addiction	23 Jan 2018	88
6	Medication adherence among patients with chronic diseases: a survey-based study in pharmacies Christoph Jüngst, Stefan Gräber, Sinno H. P. Simons et al. · QJM	4 Mar 2019	69
7	Seroprevalence of antibodies and antigens against hepatitis A–E viruses in refugees and asylum seekers in Germany in 2015 Alexandra Dopfer‐Jablonka, Philipp Solbach, Michael Wöbse et al. · European Journal of Gastroenterology & Hepatology	10 May 2017	61
8	MAIT Cells Are Enriched and Highly Functional in Ascites of Patients With Decompensated Liver Cirrhosis Christian Niehaus, Benedikt Strunz, Martin Cornillet et al. · Hepatology Open access	3 Feb 2020	60
9	Long-Lasting Imprint in the Soluble Inflammatory Milieu Despite Early Treatment of Acute Symptomatic Hepatitis C Tanvi Khera, Yanqin Du, Daniel Tödt et al. · The Journal of Infectious Diseases Open access	28 Jan 2021	47
10	Real‐world use, effectiveness and safety of anti‐viral treatment in chronic hepatitis C genotype 3 infection Markus Cornberg, J. Petersen, Andreas Leonhard Schober et al. · Alimentary Pharmacology & Therapeutics	12 Jan 2017	47
11	Significance of time awake for predicting pilots' fatigue on short‐haul flights: implications for flight duty time regulations Martin Vejvoda, Eva‐Maria Elmenhorst, Sibylle Pennig et al. · Journal of Sleep Research	21 Jul 2014	43
12	Continuous Versus Intermittent Spinal Cord Stimulation: An Analysis of Factors Influencing Clinical Efficacy Tilman Wolter, Matthias Winkelmüller · Neuromodulation Technology at the Neural Interface	12 Dec 2011	40
13	Emergence of resistance-associated variants during sofosbuvir treatment in chronically infected hepatitis E patients André Gömer, Mara Klöhn, Michelle Jagst et al. · Hepatology Open access	19 Jun 2023	33
14	Hook plate for medial clavicle fracture Justus Gille, Arndt‐Peter Schulz, S. Wallstabe et al. · Indian Journal of Orthopaedics Open access	30 Mar 2010	32
15	HBcrAg Levels Are Associated With Virological Response to Treatment With Interferon in Patients With Hepatitis Delta Lisa Sandmann, Cihan Yurdaydın, Katja Deterding et al. · Hepatology Communications Open access	24 Sep 2021	28
16	Only partial improvement in health‐related quality of life after treatment of chronic hepatitis C virus infection with direct acting antivirals in a real‐world setting—results from the German Hepatitis C‐Registry (DHC‐R) Valerie Ohlendorf, Arne Schäfer, Stefan Christensen et al. · Journal of Viral Hepatitis Open access	18 May 2021	28
17	Dynamics of liver stiffness by transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral therapy—Results from the German Hepatitis C‐Registry Viola Knop, Stefan Mauss, Tobias Goeser et al. · Journal of Viral Hepatitis	25 Feb 2020	28
18	The use of hamstrings in anterior cruciate ligament reconstruction in patients over 40 years Bastian Marquaß, Pierre Hepp, Thomas Engel et al. · Archives of Orthopaedic and Trauma Surgery	14 Apr 2007	28
19	Real-World Clinical Practice Use of 8-Week Glecaprevir/Pibrentasvir in Treatment-Naïve Patients with Compensated Cirrhosis Pietro Lampertico, Stefan Mauss, Marcello Persico et al. · Advances in Therapy Open access	4 Aug 2020	27
20	Intrathecal Opioid Therapy for Pain: Efficacy and Outcomes Wolfhard Winkelmüller, Kim J. Burchiel, Jean-Pierre Van Buyten · Neuromodulation Technology at the Neural Interface	Apr 1999	27
21	Updated epidemiology of hepatitis C virus infections and implications for hepatitis C virus elimination in Germany Tammo Lambert Tergast, Sarah Blach, Frank Tacke et al. · Journal of Viral Hepatitis Open access	31 Mar 2022	26
22	Residual low HDV viraemia is associated HDV RNA relapse after PEG‐IFNa‐based antiviral treatment of hepatitis delta: Results from the HIDIT‐II study Birgit Bremer, Olympia Evdoxia Anastasiou, Svenja Hardtke et al. · Liver International Open access	21 Nov 2020	26
23	Applicability and Validity of an e-Health Tool for the Appropriate Referral and Selection of Patients With Chronic Pain for Spinal Cord Stimulation: Results From a European Retrospective Study Simon Thomson, Frank J.P.M. Huygen, Simon J. Prangnell et al. · Neuromodulation Technology at the Neural Interface Open access	21 Jan 2022	24
24	Deutsches Hepatitis C-Register (DHC-R) – eine Zwischenbilanz 4 Jahre nach Zulassung direkt antiviraler Substanzen (DAAs) D Hüppe, Yvonne Serfert, Peter Buggisch et al. · Zeitschrift für Gastroenterologie	2019	23
25	Sofosbuvir plus velpatasvir for 8 weeks in patients with acute hepatitis C: The HepNet acute HCV-V study Benjamin Maasoumy, Patrick Ingiliz, Christoph D. Spinner et al. · JHEP Reports Open access	16 Dec 2022	22
26	Patient selection for spinal cord stimulation: The importance of an integrated assessment of clinical and psychosocial factors Simon Thomson, Nicky Helsen, Simon J. Prangnell et al. · European Journal of Pain Open access	20 Jul 2022	22
27	Effectiveness and Safety of Direct-Acting Antiviral Combination Therapies for Treatment of Hepatitis C Virus in Elderly Patients: Results from the German Hepatitis C Registry Georg Dultz et al. · Drugs & Aging Open access	7 Aug 2018	21
28	Impact of direct-acting antiviral therapy on the need for liver transplantation related to hepatitis C in Germany Kerstin Herzer et al. · Universitätsbibliographie, Universität Duisburg-Essen	2018	20
29	Clinical significance of detectable and quantifiable HCV RNA at the end of treatment with ledipasvir/sofosbuvir in GT 1 patients Benjamin Maasoumy, Peter Buggisch, Stefan Mauss et al. · Liver International	19 Jul 2018	19
30	Elevated liver enzymes predict morbidity and mortality despite antiviral cure in patients with chronic hepatitis C: Data from the German Hepatitis C‐Registry Frank Tacke, Hartwig Klinker, Klaus H. W. Boeker et al. · Hepatology Communications Open access	5 Jun 2022	18
31	Weight Gain after Interferon-Free Treatment of Chronic Hepatitis C—Results from the German Hepatitis C-Registry (DHC-R) Bernhard Schlevogt, Klaus H. W. Boeker, Stefan Mauss et al. · Biomedicines Open access	19 Oct 2021	18
32	Glecaprevir/pibrentasvir is safe and effective in hepatitis C patients with cirrhosis: Real‐world data from the German Hepatitis C‐Registry Heiner H. Wedemeyer, P. Erren, Uwe Naumann et al. · Liver International Open access	16 Feb 2021	18
33	Estimation of liver fibrosis by noncommercial serum markers in comparison with transient elastography in patients with chronic hepatitis C virus infection receiving direct‐acting antiviral treatment Viola Knop, Wolf Peter Hofmann, Peter Buggisch et al. · Journal of Viral Hepatitis Open access	13 Oct 2018	18
34	Neural-network analysis of socio-medical data to identify predictors of undiagnosed hepatitis C virus infections in Germany (DETECT) Markus Reiser, Bianka Wiebner, Jürgen Hirsch · Journal of Translational Medicine Open access	19 Mar 2019	17
35	Risk of recurrent hepatic encephalopathy in patients with liver cirrhosis: a German registry study Maria Magdalena Gabriel, GERALD KIRCHEIS, Svenja Hardtke et al. · European Journal of Gastroenterology & Hepatology	8 Jul 2020	16
36	Alcohol and Cannabis Consumption Does Not Diminish Cure Rates in a Real-World Cohort of Chronic Hepatitis C Virus Infected Patients on Opioid Substitution Therapy—Data From the German Hepatitis C-Registry (DHC-R) Stefan Christensen, Peter Buggisch, Stefan Mauss et al. · Substance Abuse Research and Treatment Open access	2019	16
37	Anterior Cruciate Ligament Reconstruction: State of the Art Christine Voigt, Marcus Schönaich, Helmut R. LILL · European Journal of Trauma	Aug 2006	16
38	Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA Benjamin Heidrich, Steffen B. Wiegand, Peter Buggisch et al. · PLoS ONE Open access	10 Oct 2014	15
39	Estimating HCV disease burden – volume 3 (editorial) Alessio Aghemo, Gregory J. Dore, Angelos E. Hatzakis et al. · Journal of Viral Hepatitis Open access	29 Oct 2015	15
40	Early‐onset, fatal interstitial lung disease in STAT3 gain‐of‐function patients Florian Gothe, Jonathan Gehrig, Christina Katharina Rapp et al. · Pediatric Pulmonology Open access	22 Sep 2021	14
41	Hepatitis C virus: Current steps toward elimination in Germany and barriers to reaching the 2030 goal Christoph Sarrazin, Christoph Boesecke, Solmaz Golsabahi‐Broclawski et al. · Health Science Reports Open access	Jun 2021	14
42	Distinct clusters of bacterial and fungal microbiota in end-stage liver cirrhosis correlate with antibiotic treatment, intestinal barrier impairment, and systemic inflammation Laura Buttler, David A. Velázquez-Ramírez, Anja Tiede et al. · Gut Microbes Open access	21 Apr 2025	13
43	Population-based screening works: Effect of integrating screening for hepatitis B and C into the general health check-up in Germany D Hüppe, Heiner H. Wedemeyer, Markus Cornberg · Journal of Hepatology Open access	3 Nov 2023	13
44	Sofosbuvir, velpatasvir, and voxilaprevir for patients with failure of previous direct-acting antiviral therapy for chronic hepatitis C: Results from the German Hepatitis C-Registry (DHC-R) Heiner H. Wedemeyer, Johannes Vermehren, Yvonne Serfert et al. · Zeitschrift für Gastroenterologie	Sep 2020	13
45	The effect of local bone mineral density on the rate of mechanical failure after surgical treatment of distal radius fractures: a prospective multicentre cohort study including 249 patients Rikli Daniel, Goldhahn Joerg, Käch Kurt et al. · Archives of Orthopaedic and Trauma Surgery	10 Dec 2014	13
46	CXCR6+CD69+ CD8+ T cells in ascites are associated with disease severity in patients with cirrhosis Christian Niehaus, Sebastian Klein, Benedikt Strunz et al. · JHEP Reports Open access	24 Mar 2024	12
47	A transient early HBV‐DNA increase during PEG‐IFNα therapy of hepatitis D indicates loss of infected cells and is associated with HDV‐RNA and HBsAg reduction Olympia Evdoxia Anastasiou, Cihan Yurdaydın, Benjamin Maasoumy et al. · Journal of Viral Hepatitis	13 Nov 2020	12
48	Versorgungsprobleme von Patienten mit chronischer Hepatitis C während der COVID-19-Pandemie und der Lockdown-Verordnungen D Hüppe, Claus Niederau, Yvonne Serfert et al. · Zeitschrift für Gastroenterologie Open access	9 Nov 2020	12
49	Long-term survival after embolization of potentially lethal bleeding malignant pelvic tumours Ph. Hendrickx, Gérard Orth, J.-H. Grunert · British Journal of Radiology	Dec 1995	12
50	Bulevirtide Monotherapy or in Combination for Chronic Hepatitis Delta: 2025 Update Pietro Lampertico, Maria Paola Anolli, Katja Steppich et al. · Journal of Viral Hepatitis Open access	24 Nov 2025	11

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.